John McKune - 01 Mar 2024 Form 4/A Insider Report for Pulmonx Corp (LUNG)

Role
INTERIM CFO
Signature
/s/ John McKune
Issuer symbol
LUNG
Transactions as of
01 Mar 2024
Transactions value $
$0
Form type
4/A
Filing time
07 Mar 2024, 19:57:55 UTC
Date Of Original Report
05 Mar 2024
Previous filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +28.8K +60.75% $0.00 76.2K 01 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +14.4K $0.00 14.4K 01 Mar 2024 Common Stock 14.4K $9.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.

Remarks:

This amendment is being filed solely to correct the inadvertent typographical errors in the number of shares underlying the Employee Stock Option and Restricted Stock Units and the total securities owned after such transactions as reported in the original Form 4 filed with the SEC on March 5, 2024.